Intra-Cellular Therapies to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 05 2021 - 8:00AM
Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical
company focused on the development and commercialization of
therapeutics for central nervous system (CNS) disorders, today
announced that Sharon Mates, Ph.D., Chief Executive Officer and
Chairman, is scheduled to present at the 39th Annual J.P. Morgan
Healthcare Conference on Tuesday, January 12, 2021 at 9:10 am ET.
The live and archived webcast can be accessed under
"Events & Presentations" in the Investor Relations section of
the Company's website at www.intracellulartherapies.com. Please log
in approximately 5-10 minutes prior to the event to register and to
download and install any necessary software.
About Intra-Cellular Therapies
Intra-Cellular Therapies is a biopharmaceutical
company founded on Nobel prize-winning research that allows us to
understand how therapies affect the inner-workings of cells in the
body. The company leverages this intracellular approach to develop
innovative treatments for people living with complex psychiatric
and neurologic diseases.
CONTACT:
Intra-Cellular Therapies, Inc.Juan Sanchez,
M.D.Vice President, Corporate Communications and Investor
Relations646-440-9333
Burns McClellan, Inc.Lisa BurnsJohn
Grimaldijgrimaldi@burnsmc.com212-213-0006
Source: Intra-Cellular Therapies Inc.
Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart
From Sep 2023 to Sep 2024